Related references
Note: Only part of the references are listed.Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death
Yu Sun et al.
CARCINOGENESIS (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Targeting protein kinases for the development of anti-inflammatory drugs
Philip Cohen
CURRENT OPINION IN CELL BIOLOGY (2009)
Present status and strategy of NSAIDs-induced small bowel injury
Kazuhide Higuchi et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Intestinal permeability in the pathogenesis of NSAID-induced enteropathy
Ingvar Bjarnason et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Frank L. Meyskens et al.
CANCER PREVENTION RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
P38 MAP-Kinases pathway regulation, function and role in human diseases
Ana Cuenda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction
Sung-Keum Seo et al.
APOPTOSIS (2007)
Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice
Emina H. Huang et al.
SURGERY (2006)
Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms
T Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Microbial flora in NSAID-induced intestinal damage: A role for antibiotics?
A Lanas et al.
DIGESTION (2006)
Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity
T Minami et al.
CLINICAL CANCER RESEARCH (2005)
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease
J Saklatvala
CURRENT OPINION IN PHARMACOLOGY (2004)
p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
S Kumar et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations
K Yang et al.
CARCINOGENESIS (2003)
Pathology of mouse models of intestinal cancer: Consensus report and recommendations
GP Boivin et al.
GASTROENTEROLOGY (2003)
Oxidative stress inactivates the human DNA mismatch repair system
CL Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Primary chemoprevention of familial adenomatous polyposis with sulindac
FM Giardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
M Cruz-Correa et al.
GASTROENTEROLOGY (2002)
The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis
HS Cooper et al.
GASTROENTEROLOGY (2001)
Share Paper
